Robotic or laparoscopic sacrohysteropexy versus open sacrohysteropexy for uterus preservation in pelvic organ prolapse

Int Urogynecol J. 2016 Apr;27(4):593-9. doi: 10.1007/s00192-015-2869-4. Epub 2015 Oct 29.

Abstract

Introduction and hypothesis: The aim of this study was to compare robotic or laparoscopic sacrohysteropexy (RLSH) and open sacrohysteropexy (OSH) as a surgical treatment for pelvic organ prolapse (POP).

Methods: Among 111 consecutive patients who had undergone sacrohysteropexy for POP, surgical outcomes and postoperative symptoms were compared between the RLSH (n = 54; robotic 14 cases and laparoscopic 40 cases) and OSH (n = 57). groups The medical records of enrolled patients were reviewed retrospectively.

Results: Compared with the OSH group, the RLSH group had shorter operating time (120.2 vs 187.5 min, p < 0.0001), less operative bleeding (median estimated blood loss 50 vs 150 ml; p < 0.0001; mean hemoglobin drop 1.4 vs 2.0 g/dl; p < 0.0001), and fewer postoperative symptoms (13 vs 45.6 %; p < 0.0001). Patients' overall satisfaction (94.4 vs 91.2 %; p = 0.717) and required reoperation due to postoperative complications (3.7 vs 1.8 %; p = 0.611) did not differ between groups.

Conclusions: RLSH could be a feasible and safe procedure in patients with POP and should be considered as a surgical option that allows preservation of the uterus. Prospective randomized trials will permit the evaluation of potential benefits of RLSH as a minimally invasive surgical approach.

Keywords: Laparoscopic sacrohysteropexy; Pelvic organ prolapse; Robotic.

Publication types

  • Comparative Study

MeSH terms

  • Aged
  • Blood Loss, Surgical
  • Female
  • Gynecologic Surgical Procedures / adverse effects
  • Gynecologic Surgical Procedures / methods*
  • Hemoglobins / metabolism
  • Humans
  • Laparoscopy* / adverse effects
  • Middle Aged
  • Operative Time
  • Organ Sparing Treatments*
  • Patient Satisfaction
  • Pelvic Organ Prolapse / surgery*
  • Postoperative Complications / etiology
  • Reoperation
  • Retrospective Studies
  • Robotic Surgical Procedures* / adverse effects
  • Uterus / surgery*

Substances

  • Hemoglobins